0001735276-24-000033.txt : 20240328
0001735276-24-000033.hdr.sgml : 20240328
20240328161717
ACCESSION NUMBER: 0001735276-24-000033
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240320
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzgerald Kevin Joseph
CENTRAL INDEX KEY: 0001886431
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 24799188
MAIL ADDRESS:
STREET 1: C/O OVID THERAPEUTICS INC.
STREET 2: 1460 BROADWAY, SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
3
1
edgardoc.xml
PRIMARY DOCUMENT
X0206
3
2024-03-20
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001886431
Fitzgerald Kevin Joseph
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE
MA
02142
0
1
0
0
CSO & EVP, Head of Research
Common Stock
12881
D
Common Stock
537
I
by Managed Account
Performance Stock Option 2017 (right to buy)
119.13
2021-02-11
2028-03-01
Common Stock
9000
D
Stock Option (right to buy)
85.0
2029-02-28
Common Stock
16250
D
Stock Option (right to buy)
97.72
2025-12-07
Common Stock
6667
D
Stock Option (right to buy)
118.05
2030-02-26
Common Stock
14580
D
Stock Option (right to buy)
119.13
2028-03-01
Common Stock
9000
D
Stock Option (right to buy)
147.47
2032-02-23
Common Stock
20382
D
Stock Option (right to buy)
151.59
2031-02-24
Common Stock
15692
D
Stock Option (right to buy)
152.61
2034-03-01
Common Stock
9279
D
Stock Option (right to buy)
190.01
2033-02-27
Common Stock
10352
D
Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter over the following thirty-three (33) months of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
Exhibit List: Exhibit 24 - Power of Attorney
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
2024-03-28